Jon Winkelried, 10% Owner at Trevi Therapeutics, Inc. (TRVI), sold 951,932 shares at $2.77 ($2.6M) on 2022-06-30, disclosed to the SEC on 2022-07-01.
Open-market sale of $2.6M TRVI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 46,128 | $126K | 4.8% |
| 2 | $2.74 | 46,128 | $126K | 4.8% |
| 3 | $2.77 | 429,838 | $1.2M | 45.2% |
| 4 | $2.77 | 429,838 | $1.2M | 45.2% |
| Total | $2.77 avg | 951,932 | $2.6M | 100% |
| Filing → |
| LFST | SELL | 2024-05-29 | $171.7M | — | Filing → |
| TPG | SELL | 2024-02-29 | $45.9M | — | Filing → |
| NXT | SELL | 2024-02-07 | $622.6M | — | Filing → |